| 溶解性 | DMSO |
| 存贮条件 | 储存温度-20°C |
| 生化机理 | Calcitonin gene-related peptide (CGRP) is closely involved in the cascade of molecular events leading to migraine painful crisis. New CGRP-R antagonist, such as BMS-927711, is in the pipeline and its developments will outline the future of this drug class. BMS-927711 has good oral bioavailability in rat and cynomolgus monkey, attractive overall preclinical properties, and shows dose-dependent activity in a primate model of CGRP-induced facial blood flow. BMS-927711 is presently in phase II clinical trials. |
BMS-927711,CGRP受体拮抗剂
BMS-927711 （订货以英文为准）
编号：B125641
CAS号：1289023-67-1
分子式：C28H28F2N6O3
分子量：534.56
| 产品名称 | BMS-927711 |
| 中文名称 | BMS-927711,CGRP受体拮抗剂 |
| CAS号 | 1289023-67-1 |
| 分子式（M.F.） | C28H28F2N6O3 |
| 分子量（M.W.） | 534.56 |
| 储存条件 | 避光;-20°C储存 |
搜索质检报告(COA)
搜索MSDS
相关产品
¥ 693.00
227-35006-01-1包
¥ 50.00
130208058-1套
¥ 120.00
120303027-1支
¥ 20.00
CR-001-81-1个
小艺 
